icosanoid

Term ID

CHEBI:23899

Synonyms

eicosanoid
eicosanoids
icosanoid
icosanoids

Definition

Any member of the group of signalling molecules arising from oxidation of the three C20 essential fatty acids (EFAs) icosapentaenoic acid (EPA), arachidonic acid (AA) and dihomo-gamma-linolenic acid (DGLA).

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: fatty acid derivative

fatty acid derivative Show first 5 Terms
has subtype: (+/-)11-HEDE (2R)-2-Hydroxy-3-(icosanoyloxy)propyl (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate (5Z,9E,12S,14Z)-8,11,12,20-tetrahydroxyicosa-5,9,14-trienoic acid (6E,8Z,10E,12S,14Z)-12-hydroxy-5-oxoicosatetraenoic acid (6E,8Z,11Z,13E,15S)-15-hydroxy-5-oxoicosatetraenoic acid ... Show All 102 Terms

(+/-)11-HEDE (2R)-2-Hydroxy-3-(icosanoyloxy)propyl (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate (5Z,9E,12S,14Z)-8,11,12,20-tetrahydroxyicosa-5,9,14-trienoic acid (6E,8Z,10E,12S,14Z)-12-hydroxy-5-oxoicosatetraenoic acid (6E,8Z,11Z,13E,15S)-15-hydroxy-5-oxoicosatetraenoic acid (6E,8Z,11Z,14Z,17Z)-5-oxoicosapentaenoic acid (7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoic acid (15E,17E)-9,10,12,13-tetrahydroxyhenicosa-15,17-dienoic acid 5(S),6(S)-epoxy-18(R)-hydroxy-(7E,9E,11Z,14Z,16E)-icosapentaenoic acid 5(S),6(S)-epoxy-18-hydroxy-(7E,9E,11Z,14Z,16E)-icosapentaenoic acid 5,8,11-icosatriynoic acid 5,20-diHEPE 11R-HEDE 11S-HEDE 12-HPE(8,10,14)TrE 12-Keto-tetrahydro-LTB4 13,14-dihydro-15-oxolipoxin A4 13,14-dihydrolipoxin A4 14-carboxy-15,16,17,18,19,20-hexanor-leukotriene E3 15R-HEDE 16-carboxy-17,18,19,20-tetranor-leukotriene E3 16-carboxy-Delta(13)-17,18,19,20-tetranor-leukotriene E4 18-carboxy-19,20-dinor-leukotriene E4 Auricolic acid bis(hydroperoxy)icosatetraenoic acid CA-phytotoxin CDP-DG(20:2(11Z,14Z)/6 keto-PGF1alpha) CDP-DG(20:3(5Z,8Z,11Z)/PGE1) CDP-DG(20:4(5Z,8Z,11Z,14Z)/PGF2alpha) CDP-DG(22:3(10Z,13Z,16Z)/5-iso PGF2VI) CDP-DG(22:3(10Z,13Z,16Z)/PGE2) CDP-DG(PGE2/20:2(11Z,14Z)) CDP-DG(PGE2/20:3(5Z,8Z,11Z)) CDP-DG(PGE2/22:3(10Z,13Z,16Z)) CDP-DG(PGF1alpha/22:3(10Z,13Z,16Z)) CDP-DG(PGJ2/20:2(11Z,14Z)) DG(8:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) DG(13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) DG(14:1n5/0:0/20:5n3) DG(15:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) DG(16:1n7/0:0/20:5n3) DG(18:1n7/0:0/20:5n3) DG(18:1n9/0:0/20:5n3) DG(18:2n6/0:0/20:4n3) DG(18:2n6/0:0/20:5n3) DG(18:3n3/0:0/20:4n3) DG(18:3n6/0:0/20:3n6) DG(18:3n6/0:0/20:4n3) DG(18:3n6/0:0/20:4n6) DG(19:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) DG(20:2n6/0:0/18:4n3) DG(20:2n6/0:0/20:4n3) DG(20:2n6/0:0/20:4n6) DG(20:2n6/0:0/20:5n3) DG(20:3n6/0:0/18:3n3) DG(20:3n6/0:0/18:4n3) DG(20:3n6/0:0/20:4n3) DG(20:3n6/0:0/20:4n6) DG(20:3n9/0:0/18:3n3) DG(20:3n9/0:0/18:3n6) DG(20:3n9/0:0/18:4n3) DG(20:3n9/0:0/20:4n3) DG(20:3n9/0:0/20:4n6) DG(20:4n6/0:0/18:3n3) DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/12:0/0:0) DHET dihydroxyicosatetraenoic acid EET eoxin EpETE HETE HPETE hydroperoxy(epoxy)icosatrienoic acid hydroperoxy(hydroxy)icosapentaenoic acid hydroperoxy(hydroxy)icosatetraenoic acid Hydroperoxy-eicosadienoic acid hydroperoxyicosapentaenoic acid hydroperoxyicosatrienoic acid icosenoic acid isoprostane leukotriene levuglandin methyl 6-hydroperoxy-4,8,11,14,17-eicosapentaenoate methyl 8-hydroperoxy-5,9,11,14,17-eicosapentaenoate methyl 9-hydroperoxy-5,7,11,14,17-eicosapentaenoate Mycestericin A Myriocin-12-en nonclassic icosanoid PI(6 keto-PGF1alpha/20:2(11Z,14Z)) PI(20:2(11Z,14Z)/PGF2alpha) PI(20:3(5Z,8Z,11Z)/PGE1) PI(20:3(5Z,8Z,11Z)/PGF1alpha) PI(20:3(5Z,8Z,11Z)/PGF2alpha) PI(20:4(5Z,8Z,11Z,14Z)/PGJ2) PI(22:3(10Z,13Z,16Z)/PGE1) PI(22:3(10Z,13Z,16Z)/PGF1alpha) PI(22:3(10Z,13Z,16Z)/TXB2) PI(PGE2/20:4(5Z,8Z,11Z,14Z)) PI(PGE2/22:3(10Z,13Z,16Z)) PI(PGJ2/20:3(5Z,8Z,11Z)) PI(TXB2/22:3(10Z,13Z,16Z)) prostanoid Show first 5 Terms
inverse is_conjugate_base_of: icosanoid anion

icosanoid anion Show first 5 Terms
is_conjugate_acid_of: icosanoid anion

icosanoid anion Show first 5 Terms

Phenotype

Phenotype resulting from icosanoid

Phenotype where environments contain icosanoid

Phenotype modified by environments containing icosanoid

Human Disease Model